Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glutamate and epilepsy.

A G Chapman1

  • 1Department of Clinical Neuroscience, Institute of Psychiatry, London, England.

The Journal of Nutrition
|March 29, 2000
PubMed
Summary
This summary is machine-generated.

Glutamate receptors, crucial in epilepsy, show enhanced activity in acquired epilepsy models and human temporal lobe epilepsy. Targeting these receptors with antagonists may offer effective seizure control.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain regional amino acid levels in seizure susceptible rats: Changes related to sound-induced seizures.

Neurochemistry international·2010
Same author

Temperature response of oxygen uptake in brain mitochondria from normal and ischemic rats.

Neurochemistry international·2010
Same author

Anticonvulsant activity of a mGlu(4alpha) receptor selective agonist, (1S,3R,4S)-1-aminocyclopentane-1,2,4-tricarboxylic acid.

European journal of pharmacology·2001
Same author

Anti-epileptic activity of group II metabotropic glutamate receptor agonists (--)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (--)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY389795).

Neuropharmacology·2001
Same author

Anticonvulsant activity of 3,4-dicarboxyphenylglycines in DBA/2 mice.

Neuropharmacology·2001
Same author

The mGlu(2/3) agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate, is anti- and proconvulsant in DBA/2 mice.

Neuroscience letters·2001
Same journal

Evaluation of Energy and Nutrient Estimates from Large Language Models Using Text-Based Queries.

The Journal of nutrition·2026
Same journal

Considerations for Dietary Supplements After GLP-1RA Treatment: A Narrative Review.

The Journal of nutrition·2026
Same journal

The apple(juice) doesn't fall far from the tree: Children's hydration mirrors their parent's.

The Journal of nutrition·2026
Same journal

Microbial-derived polyphenol metabolites and the gut microbiota: A scoping review of clinical studies.

The Journal of nutrition·2026
Same journal

Hesperidin as an Emerging Nutraceutical in Modern Health and Preventive Medicine: A Narrative Review.

The Journal of nutrition·2026
Same journal

Short-Chain Fatty Acids in Livestock and Aquatic Animals: Metabolic Divergence, Physiological Functions, and Product Development.

The Journal of nutrition·2026
See all related articles

Area of Science:

  • Neuroscience
  • Epileptology
  • Molecular Biology

Background:

  • Epileptic syndromes stem from diverse genetic, developmental, or acquired origins.
  • Glutamate signaling is implicated in seizure initiation and spread across epilepsy types.
  • Rodent models demonstrate that manipulating glutamate receptor/transporter expression affects seizure activity.

Purpose of the Study:

  • To investigate the role of glutamate receptors in epilepsy.
  • To explore the efficacy of targeting glutamate receptors for anticonvulsant effects.

Main Methods:

  • Analysis of rodent models with altered glutamate receptor/transporter expression (knockout/knockdown).
  • Examination of glutamate receptor function in acquired epilepsy models and human temporal lobe epilepsy.

Related Experiment Videos

  • Assessment of anticonvulsant actions of antagonists targeting N-methyl-D-aspartate (NMDA) and Group I metabotropic receptors.

    • Main Results:

    • Enhanced functional efficacy of ionotropic NMDA and Group I metabotropic receptors observed in acquired epilepsy models and human epilepsy.
    • Antagonists targeting NMDA and Group I metabotropic receptors demonstrate potent anticonvulsant effects in animal models.

    Conclusions:

    • Synaptically released glutamate acting on ionotropic and metabotropic receptors is pivotal in epilepsy.
    • Targeting NMDA and Group I metabotropic receptors represents a promising therapeutic strategy for epilepsy treatment.